2,3,4,5-Tetrachloronitrobenzene

We are 2,3,4,5-Tetrachloronitrobenzene CAS:879-39-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 879-39-0
Product Name: 2,3,4,5-Tetrachloronitrobenzene
Other Name:
2,3,4,5-Tetrachloronitrobenzene
1,2,3,4-Tetrachlor-5-nitro-benzol
1,2,3,4-Tetrachloro-5-nitro-benzene
3,5-dichloro-2,4-dichloronitrobenzene
1-Nitro-2,3,4,5-tetrachlorobenzene
5-nitro-1,2,3,4-tetrachloro-benzen
 
Density: 1.75g/cm3
Boiling Point: 315.2ºC at 760 mmHg
Melting Point: 65°C
Molecular Formula: C6HCl4NO2
Molecular Weight: 260.89000
Flash Point: 144.4ºC
Exact Mass: 258.87600
PSA: 45.82000
LogP: 4.73160
Index of Refraction: 1.62
 
Specification
Appearance: White solid
Loss on drying: ≤2.0%
Heavy metals: ≤10 ppm
Water: ≤1.0%
Sulphated ash: ≤0.5%
Single impurity: ≤0.10%
Total Impurity: ≤0.5%
Purity: ≥99.0%
Assay: 99.0%~101.0%
 
Application
Intermediates of Teflubenzuron CAS: 83121-18-0.
Be used as pesticide intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,3,4,5-Tetrachloronitrobenzene


Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).O-(N-Succinimidyl)-1,1,3,3-tetramethyluronium tetrafluoroborate CAS:105832-38-0 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).N-(4-ethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide CAS:4711-68-6 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.2,2,2-Trichloroethyl chloroformate CAS:17341-93-4 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.

Related Products
Product Name
Cytidine 5′-triphosphate disodium salt View Details
(1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane View Details
2-Chloroadenine View Details
Sinalbin manufacturer Methyl 6-(trifluoromethyl)-1h-indole-2-carboxylate manufacturer 5,6-Dichloroindolin-2-one manufacturer N,N’-Bis(benzyloxycarbonyl)-L-cystine manufacturer 3-Iodoanisole manufacturer